Ainuovirine

Other namesACC-007, KM-023, Aibangde, Einovirine

CAS Number

• 1097628-00-6

PubChem CID

• 25215428

ChemSpider

• 24662280

Ainuovirine

Clinical data
Other names	ACC-007, KM-023, Aibangde, Einovirine
Identifiers
IUPAC name 3-(3-ethyl-2,6-dioxo-5-propan-2-ylpyrimidine-4-carbonyl)-5-methylbenzonitrile
CAS Number	1097628-00-6
PubChem CID	25215428
ChemSpider	24662280
ChEMBL	ChEMBL1081658
PDB ligand	KRV (PDBe, RCSB PDB)
Chemical and physical data
Formula	C18H19N3O3
Molar mass	325.368 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCN1C(=C(C(=O)NC1=O)C(C)C)C(=O)C2=CC(=CC(=C2)C#N)C
InChI InChI=InChI=1S/C18H19N3O3/c1-5-21-15(14(10(2)3)17(23)20-18(21)24)16(22)13-7-11(4)6-12(8-13)9-19/h6-8,10H,5H2,1-4H3,(H,20,23,24) Key:AYPIJAMXGVYYRQ-UHFFFAOYSA-N

Ainuovirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) being developed by Kainos Medicine for the treatment of HIV infections.^[1] Ainuovirine was approved in China in 2021 for the treatment of HIV-1 infection.^[2]